Rodriguez International Holding LLC is pleased to announce a new alliance with DNActive, a leading Spanish company in the health sector, focused on Genetics services.
Our company has made an alliance to represent in the United Arab Emirates the prominent DNActive Spanish Clinic specialized in identifying the main genetic risks of the person and families through different modules of screening for pathologies of different medical specialties.
DNActive valued in 2019 at more than two million euros identifies the main genetic risks of people, through different pathological screening modules and pharmacogenetically identifies drugs. Analyze which is the most appropriate dose of drugs for each person.
Genetic tests are used to identify variants that experience the risk of a person Developing a disease of genetic origin, as is the case with some types of cancer and pathologies of different medical specialties.
With the promising future that the genetic industry has every day that contributes to the growth and technological development of a country, the company Rodríguez International Holding LLC is interested in the search to increase its possibilities of agreements in Genetics to help the country quickly detect numerous diseases as:
- Oncology
- Cardiology
- Digestive
- Nutrigenetics
- Allergology
- Dermatology
- Neurocrine
- Dentistry
- Neurology
- Sports Medicine
- Rheumatology
- Gynecology
- Hematology
- Biomarkers
- Pharmacogenetics
- Monogenetic diseases